Published in BMC Health Serv Res on July 05, 2006
How established wait time benchmarks significantly underestimate total wait times for cardiac surgery. Can J Cardiol (2010) 1.47
Overestimation of the probability of death on peritoneal dialysis by the Kaplan-Meier method: advantages of a competing risks approach. BMC Nephrol (2012) 0.95
Do women spend longer on wait lists for coronary bypass surgery? Analysis of a population-based registry in British Columbia, Canada. BMC Cardiovasc Disord (2007) 0.80
English NHS waiting times: what next? J R Soc Med (2009) 0.75
Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med (1999) 22.81
Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol (1993) 13.16
Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet (1994) 11.37
Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med (2005) 6.53
Non-parametric inference for cumulative incidence functions in competing risks studies. Stat Med (1997) 6.12
Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med (1993) 4.60
Effect of socioeconomic deprivation on waiting time for cardiac surgery: retrospective cohort study. BMJ (2000) 4.21
Co-morbidity data in outcomes research: are clinical data derived from administrative databases a reliable alternative to chart review? J Clin Epidemiol (2000) 3.27
Creating a population-based linked health database: a new resource for health services research. Can J Public Health (1998) 3.05
Cause of death. Proper completion of the death certificate. JAMA (1987) 2.68
Death on the waiting list for cardiac surgery in The Netherlands in 1994 and 1995. Heart (1999) 2.40
Waiting times and prioritization for coronary artery bypass surgery in New Zealand. Heart (1999) 1.81
Waiting for cardiac surgery: results of a risk-stratified queuing process. Circulation (2001) 1.71
A survey of provider experiences and perceptions of preferential access to cardiovascular care in Ontario, Canada. Ann Intern Med (1998) 1.66
Managed delay for coronary artery bypass graft surgery: the experience at one Canadian center. J Am Coll Cardiol (1996) 1.55
Time on wait lists for coronary bypass surgery in British Columbia, Canada, 1991-2000. BMC Health Serv Res (2005) 1.27
Morbidity and mortality in patients waiting for coronary artery bypass surgery. Eur J Cardiothorac Surg (2001) 1.14
Waiting for coronary revascularization: a comparison between New York State, The Netherlands and Sweden. Health Policy (1997) 1.08
Priority points and cardiac events while waiting for coronary bypass surgery. Heart (1999) 1.06
Improving estimates of event incidence over time in populations exposed to other events: application to three large databases. J Clin Epidemiol (2003) 1.06
Mortality on the waiting list for coronary artery bypass grafting: incidence and risk factors. Ann Thorac Surg (2004) 0.99
Reliability audit of a regional cardiac surgery registry. J Thorac Cardiovasc Surg (1997) 0.93
Do longer delays for coronary artery bypass surgery contribute to preoperative mortality in less urgent patients? Med Care (2006) 0.92
Decline of acute myocardial infarction death rates not due to cause of death coding. Can J Public Health (1990) 0.88
Using observational data to estimate prognosis: an example using a coronary artery disease registry. Stat Med (2001) 0.88
Semiparametric models for cumulative incidence functions. Biometrics (2004) 0.87
Summarizing the probability of wait-list events*. J Eval Clin Pract (2005) 0.79
The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet (2006) 7.17
Does this dyspneic patient in the emergency department have congestive heart failure? JAMA (2005) 6.14
Oral fluoroquinolones and the risk of retinal detachment. JAMA (2012) 4.43
The risk for myocardial infarction with cyclooxygenase-2 inhibitors: a population study of elderly adults. Ann Intern Med (2005) 3.82
Adult Asthma Consensus Guidelines update 2003. Can Respir J (2004) 3.61
A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet (2004) 3.52
Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med (2014) 3.50
Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic. J Infect Dis (2008) 3.38
Delay in diagnosis among hospitalized patients with active tuberculosis--predictors and outcomes. Am J Respir Crit Care Med (2002) 3.10
Economic burden of asthma: a systematic review. BMC Pulm Med (2009) 3.10
The cost-effectiveness of drug-eluting stents: a systematic review. CMAJ (2006) 3.00
Bronchodilator use and the risk of arrhythmia in COPD: part 1: Saskatchewan cohort study. Chest (2012) 2.65
Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N Engl J Med (2014) 2.53
Probabilistic Markov model to assess the cost-effectiveness of bronchodilator therapy in COPD patients in different countries. Value Health (2005) 2.32
Use of oral bisphosphonates and the risk of aseptic osteonecrosis: a nested case-control study. J Rheumatol (2008) 2.08
Expanding access to HAART: a cost-effective approach for treating and preventing HIV. AIDS (2010) 2.04
Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding. CMAJ (2007) 2.02
Self-reported Morisky score for identifying nonadherence with cardiovascular medications. Ann Pharmacother (2004) 1.96
Traditional risk factors and a Genetic Risk Score are associated with age of first acute coronary syndrome. Heart (2014) 1.95
Discontinuation of statin therapy following an acute myocardial infarction: a population-based study. Eur Heart J (2008) 1.94
Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J Am Coll Cardiol (2006) 1.91
Time variations in the risk of myocardial infarction among elderly users of COX-2 inhibitors. CMAJ (2006) 1.82
Statins in COPD: a systematic review. Chest (2009) 1.82
Respiratory disease associated with solid biomass fuel exposure in rural women and children: systematic review and meta-analysis. Thorax (2011) 1.80
Adverse drug events associated with the antidotes for methanol and ethylene glycol poisoning: a comparison of ethanol and fomepizole. Ann Emerg Med (2008) 1.72
Isotretinoin and risk for inflammatory bowel disease: a nested case-control study and meta-analysis of published and unpublished data. JAMA Dermatol (2013) 1.70
Risk factors and outcomes associated with chronic obstructive pulmonary disease exacerbations requiring hospitalization. Can Respir J (2009) 1.70
Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopnea. Arch Intern Med (2006) 1.68
The cost-effectiveness of screening for colorectal cancer. CMAJ (2010) 1.67
Risk factors of hospitalization and readmission of patients with COPD exacerbation--systematic review. Int J Chron Obstruct Pulmon Dis (2007) 1.67
Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation. BMC Health Serv Res (2006) 1.64
Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The RISCA (recurrence and inflammation in the acute coronary syndromes) study. J Am Coll Cardiol (2008) 1.64
Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: A population-based, nested case-control analysis. Am J Epidemiol (2006) 1.59
Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis. CMAJ (2012) 1.55
Targeting lung attacks. Thorax (2011) 1.53
Treating the right patient at the right time: access to specialist consultation and non-invasive testing. Can J Cardiol (2006) 1.52
Cost-effectiveness of rhythm versus rate control in atrial fibrillation. Ann Intern Med (2004) 1.52
Oral contraceptives and the risk of gallbladder disease: a comparative safety study. CMAJ (2011) 1.52
The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. J Am Coll Cardiol (2003) 1.52
Determinants of hospital length of stay among patients with pneumonia admitted to a large Canadian hospital from 1991 to 2001. Can Respir J (2005) 1.52
Usefulness of soluble fas levels for improving diagnostic accuracy and prognosis for acute coronary syndromes. Am J Cardiol (2010) 1.51
Coronary revascularization in diabetic patients: a systematic review and Bayesian network meta-analysis. Ann Intern Med (2014) 1.46
Statin use and risk of epilepsy: a nested case-control study. Neurology (2010) 1.45
Dietary measures and exercise training contribute to improvement of endothelial function and atherosclerosis even in patients given intensive pharmacologic therapy. J Cardiopulm Rehabil (2006) 1.44
End-user involvement in health technology assessment (HTA) development: a way to increase impact. Int J Technol Assess Health Care (2005) 1.44
Impact of reference-based pricing for histamine-2 receptor antagonists and restricted access for proton pump inhibitors in British Columbia. CMAJ (2002) 1.43
The effect of waiting time on pain intensity after elective surgical lumbar discectomy. Spine J (2013) 1.42
Contemporary cost analysis of single instillation of mitomycin after transurethral resection of bladder tumor in a universal health care system. Urology (2010) 1.42
Bronchodilator use and the risk of arrhythmia in COPD: part 2: reassessment in the larger Quebec cohort. Chest (2012) 1.42
A guide to the translation of the Global Initiative for Asthma (GINA) strategy into improved care. Eur Respir J (2012) 1.39
Dispensation of long-acting β agonists with or without inhaled corticosteroids, and risk of asthma-related hospitalisation: a population-based study. Thorax (2013) 1.39
The value of thoracic computed tomography scans in clinical diagnosis: a prospective study. Can Respir J (2006) 1.39
Willingness to pay to eliminate the risk of restenosis following percutaneous coronary intervention: a contingent valuation. Circ Cardiovasc Qual Outcomes (2010) 1.39
The lack of association between bacille Calmette-Guerin vaccination and clustering of Aboriginals with tuberculosis in western Canada. Can Respir J (2005) 1.38
Outcomes of emergency department patients presenting with adverse drug events. Ann Emerg Med (2011) 1.34
Implementing practice guidelines: a workshop on guidelines dissemination and implementation with a focus on asthma and COPD. Can Respir J (2006) 1.32
Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review. CMAJ (2005) 1.31
Time on wait lists for coronary bypass surgery in British Columbia, Canada, 1991-2000. BMC Health Serv Res (2005) 1.27
Intake of selenium in the prevention of prostate cancer: a systematic review and meta-analysis. Cancer Causes Control (2005) 1.27
Associations of ambient air pollution with chronic obstructive pulmonary disease hospitalization and mortality. Am J Respir Crit Care Med (2013) 1.24
Management of acute asthma in adults in the emergency department: nonventilatory management. CMAJ (2009) 1.24
Asthma control in Canada: no improvement since we last looked in 1999. Can Fam Physician (2007) 1.24
Evaluating adverse drug event reporting in administrative data from emergency departments: a validation study. BMC Health Serv Res (2013) 1.23
Impact of care at a multidisciplinary congestive heart failure clinic: a randomized trial. CMAJ (2005) 1.23
Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis. JAMA Intern Med (2016) 1.21
Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease. Brain (2011) 1.20
Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis. Pharmacoepidemiol Drug Saf (2009) 1.19
Effect of number of medications on cardiovascular therapy adherence. Ann Pharmacother (2002) 1.19
Age-specific progression of nigrostriatal dysfunction in Parkinson's disease. Ann Neurol (2011) 1.19
Management of acute asthma in adults in the emergency department: assisted ventilation. CMAJ (2009) 1.16
Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study. Arthritis Rheum (2011) 1.14
Psychological distress and cancer survival: a follow-up 10 years after diagnosis. Psychosom Med (2003) 1.13
Predictors of clustering of tuberculosis in Greater Vancouver: a molecular epidemiologic study. CMAJ (2002) 1.12
Lifestyle variables and the risk of myocardial infarction in the general practice research database. BMC Cardiovasc Disord (2007) 1.12
A sensitivity analysis using information about measured confounders yielded improved uncertainty assessments for unmeasured confounding. J Clin Epidemiol (2007) 1.11
Gout, allopurinol use, and heart failure outcomes. Arch Intern Med (2010) 1.10
Does this patient with liver disease have cirrhosis? JAMA (2012) 1.09
Resource use study in COPD (RUSIC): a prospective study to quantify the effects of COPD exacerbations on health care resource use among COPD patients. Can Respir J (2007) 1.09
Personal privacy and public health: potential impacts of privacy legislation on health research in Canada. Can J Public Health (2008) 1.08
Fluctuating inflammatory markers in patients with stable ischemic heart disease. Arch Intern Med (2005) 1.07
Associations between ambient air pollution and daily mortality among elderly persons in Montreal, Quebec. Sci Total Environ (2013) 1.06
Rehabilitating digoxin. Eur Heart J (2005) 1.05
Elevated risk of asthma after hospitalization for respiratory syncytial virus infection in infancy. Paediatr Respir Rev (2013) 1.05
Trends in asthma-related direct medical costs from 2002 to 2007 in British Columbia, Canada: a population based-cohort study. PLoS One (2012) 1.05
Does wait-list size at registration influence time to surgery? Analysis of a population-based cardiac surgery registry. Health Serv Res (2006) 1.05
Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based study. Am J Hum Genet (2004) 1.05
Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study. Circulation (2004) 1.05
Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy. J Infect Dis (2004) 1.04
Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials. BMC Cardiovasc Disord (2010) 1.02
The epidemiologic burden of hepatitis C virus infection in Latin America . Ann Hepatol (2012) 1.00
Fibrinolysis or primary PCI in myocardial infarction. N Engl J Med (2013) 1.00
The revised 2014 GINA strategy report: opportunities for change. Curr Opin Pulm Med (2015) 1.00
Acute rejection and chronic nephropathy: a systematic review of the literature. Transplantation (2009) 0.99
Randomized trial of problem-based versus didactic seminars for disseminating evidence-based guidelines on asthma management to primary care physicians. J Contin Educ Health Prof (2004) 0.98
Lack of regional selectivity during the progression of Parkinson disease: implications for pathogenesis. Arch Neurol (2004) 0.98
Risk of acute kidney injury associated with the use of fluoroquinolones. CMAJ (2013) 0.98
Assessment and management of acute coronary syndromes (ACS): a Canadian perspective on current guideline-recommended treatment--part 2: ST-segment elevation myocardial infarction. Can J Cardiol (2011) 0.98